Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aplion Medical
AddedFeb 16, 2024
UpdatedJun 18, 2026
Aplion Medical

Aplion Medical

Aplion Medical: Innovating wound care technology for chronic patients across healthcare settings.

HQ
Murfreesboro, TN, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Aplion Medical, founded with a mission to innovate wound care technology, focuses on addressing the needs of patients with chronic, hard-to-heal wounds. The company aims to support clinicians and health services across various settings, including homecare, extended care, hospitals, clinics, and physician offices. Aplion Medical's flagship product is the Acton Topical Delivery System, designed to enhance the treatment of difficult wounds through advanced topical solutions.

Notable figures affiliated with Aplion Medical include experienced advisors in the medical and healthcare technology fields. The company has achieved significant milestones in developing effective wound care solutions that improve patient outcomes and streamline care processes for healthcare providers. Aplion Medical's impact is evident in its contribution to advancing wound care technology and supporting healthcare professionals in delivering better patient care.

Aplion Medical - Similar Companies

Healogics logo

Healogics

healogics.com

WoundForce logo

WoundForce

Wound Care Technologies logo

Wound Care Technologies

The Wound logo

The Wound

woundmdhealth.com

Aatru Medical logo

Aatru Medical

aatru.com

Emunamedica logo

Emunamedica

Urgo Medical North America logo

Urgo Medical North America

urgomedical.com

Vohra Wound Physicians logo

Vohra Wound Physicians

vohrawoundcare.com

O2 RegenTech logo

O2 RegenTech

WoundZoom logo

WoundZoom

perceptivesol.com

Astrana Health logo

Astrana Health

apollomed.net

Biowound Solutions logo

Biowound Solutions

Telemedicine Solutions logo

Telemedicine Solutions

woundrounds.com

Ulcer Solutions logo

Ulcer Solutions

ulcersolutions.com

Innovative Healthcare logo

Innovative Healthcare

Aplion Medical - Quick Facts

Who are Aplion Medical's competitors?

Companies similar to Aplion Medical include Healogics, WoundForce, Wound Care Technologies and The Wound.

When was Aplion Medical founded?

Aplion Medical was founded in 2012.

Where is Aplion Medical's headquarters located?

Aplion Medical's headquarters is located in Murfreesboro, TN, US.

When was Aplion Medical's last funding round?

Aplion Medical's most recent funding round was for $1.8M (USD) in June 2014.

How much has Aplion Medical raised to-date?

As of Jun 27, 2014, Aplion Medical has raised a total of $1.8M (USD).

How many employees does Aplion Medical have?

Aplion Medical has 3 employees as of Feb 5, 2024.

Aplion Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Technology
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Wound Care
Tags
  • Healthtech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified